I. Introduction
At the wake of the COVID-19 global pandemic, it has become increasingly clear that the lack of readily deployable, portable, low-cost, point-of-care diagnostic and imaging instrument can significantly hinder the prompt diagnosis and treatment of affected patients. Conventionally, pulse oximetry is widely utilized as the palliative care option to indirectly check patient ventilation health in resource-limited setting, however the use of this device has been cautioned due to the fluctuating accuracy from motion artifacts, device-to-device variations, existing patient medical conditions (e.g. poor peripheral perfusion) [1]. Most importantly, respiratory functions of the lungs are critical organs being affected by COVID-19 viruses and must be the center of care and continuous monitoring. It is thereby imperative to have the proper imaging instruments readily available to track patient respiratory health. Electrical impedance tomography (EIT) [2] sensor is a highly promising imaging modality that is cost-effective, easy-to-operate and a potentially personalizable, wearable sensor, making it particularly useful in overcrowded hospital setting and resource-constrained healthcare environments.